Concepts (209)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuroprotective Agents | 10 | 2024 | 269 | 1.920 |
Why?
|
| Diterpenes | 9 | 2023 | 97 | 1.680 |
Why?
|
| Hippocampus | 13 | 2025 | 594 | 1.570 |
Why?
|
| Cholinesterase Inhibitors | 4 | 2025 | 44 | 0.890 |
Why?
|
| Receptors, Nicotinic | 4 | 2012 | 114 | 0.690 |
Why?
|
| Isoflurophate | 3 | 2024 | 11 | 0.630 |
Why?
|
| Nicotinic Antagonists | 4 | 2012 | 36 | 0.590 |
Why?
|
| Rats, Sprague-Dawley | 14 | 2024 | 1766 | 0.590 |
Why?
|
| Spermine | 8 | 2000 | 67 | 0.550 |
Why?
|
| Brain | 11 | 2015 | 1472 | 0.510 |
Why?
|
| N-Methylaspartate | 5 | 2012 | 59 | 0.470 |
Why?
|
| Persian Gulf Syndrome | 2 | 2025 | 4 | 0.460 |
Why?
|
| Neurosciences | 1 | 2015 | 34 | 0.450 |
Why?
|
| Synapses | 2 | 2015 | 185 | 0.450 |
Why?
|
| Rats | 25 | 2024 | 3735 | 0.440 |
Why?
|
| Research Personnel | 1 | 2015 | 206 | 0.420 |
Why?
|
| Research | 1 | 2015 | 181 | 0.420 |
Why?
|
| GABA Antagonists | 1 | 2012 | 29 | 0.390 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2013 | 38 | 0.390 |
Why?
|
| Paraoxon | 2 | 2015 | 10 | 0.380 |
Why?
|
| Animals | 38 | 2025 | 16992 | 0.380 |
Why?
|
| Excitatory Amino Acid Agonists | 2 | 2003 | 43 | 0.360 |
Why?
|
| Acetylcholinesterase | 3 | 2015 | 56 | 0.310 |
Why?
|
| Brain Ischemia | 2 | 2023 | 189 | 0.270 |
Why?
|
| Neurons | 7 | 2024 | 1263 | 0.270 |
Why?
|
| Putrescine | 4 | 1993 | 27 | 0.270 |
Why?
|
| Atropine | 3 | 2015 | 12 | 0.250 |
Why?
|
| Potassium Channels | 1 | 2025 | 80 | 0.230 |
Why?
|
| Memory Disorders | 1 | 2025 | 77 | 0.220 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2024 | 21 | 0.220 |
Why?
|
| Electric Organ | 4 | 1999 | 20 | 0.210 |
Why?
|
| Environment | 5 | 1990 | 149 | 0.210 |
Why?
|
| Pralidoxime Compounds | 2 | 2015 | 5 | 0.210 |
Why?
|
| Muscle Proteins | 3 | 1999 | 51 | 0.200 |
Why?
|
| Cerebral Cortex | 7 | 2006 | 306 | 0.200 |
Why?
|
| Receptor, Bradykinin B2 | 2 | 2013 | 13 | 0.190 |
Why?
|
| Male | 17 | 2025 | 23409 | 0.190 |
Why?
|
| Eflornithine | 3 | 1993 | 18 | 0.190 |
Why?
|
| Pyridostigmine Bromide | 2 | 2025 | 6 | 0.170 |
Why?
|
| Nerve Tissue Proteins | 3 | 1999 | 386 | 0.170 |
Why?
|
| Encephalitis | 1 | 2021 | 43 | 0.170 |
Why?
|
| Phencyclidine | 2 | 1999 | 19 | 0.160 |
Why?
|
| Hypoxia, Brain | 1 | 2000 | 7 | 0.160 |
Why?
|
| Stroke | 2 | 2015 | 340 | 0.150 |
Why?
|
| Lipopolysaccharides | 1 | 2021 | 239 | 0.150 |
Why?
|
| Exploratory Behavior | 5 | 1994 | 78 | 0.150 |
Why?
|
| Cell Differentiation | 2 | 2015 | 638 | 0.140 |
Why?
|
| Calcium Channel Blockers | 1 | 1997 | 55 | 0.130 |
Why?
|
| Anxiety | 1 | 2025 | 874 | 0.130 |
Why?
|
| Muscle, Skeletal | 1 | 1999 | 316 | 0.130 |
Why?
|
| Biogenic Polyamines | 3 | 1993 | 7 | 0.130 |
Why?
|
| Female | 10 | 2025 | 24698 | 0.120 |
Why?
|
| Action Potentials | 3 | 2013 | 246 | 0.120 |
Why?
|
| Organ Culture Techniques | 2 | 2013 | 101 | 0.120 |
Why?
|
| Disease Models, Animal | 3 | 2025 | 1596 | 0.120 |
Why?
|
| Calcium Channels | 2 | 1995 | 73 | 0.120 |
Why?
|
| CA1 Region, Hippocampal | 2 | 2012 | 35 | 0.120 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 4 | 2006 | 135 | 0.120 |
Why?
|
| Bradykinin | 2 | 2013 | 25 | 0.120 |
Why?
|
| Receptors, Cholinergic | 3 | 2006 | 28 | 0.110 |
Why?
|
| Parasympatholytics | 2 | 2011 | 6 | 0.110 |
Why?
|
| Metabolome | 1 | 2015 | 51 | 0.110 |
Why?
|
| Microsomes, Liver | 1 | 2015 | 75 | 0.110 |
Why?
|
| Calcium | 3 | 2006 | 491 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2006 | 300 | 0.110 |
Why?
|
| Peptides | 1 | 1997 | 372 | 0.110 |
Why?
|
| Spermidine | 3 | 1990 | 34 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2011 | 1124 | 0.100 |
Why?
|
| Psychomotor Disorders | 1 | 2012 | 9 | 0.100 |
Why?
|
| Torpedo | 5 | 1999 | 41 | 0.090 |
Why?
|
| Receptor, Bradykinin B1 | 1 | 2012 | 6 | 0.090 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2012 | 78 | 0.090 |
Why?
|
| Cell Survival | 1 | 2015 | 945 | 0.090 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 506 | 0.090 |
Why?
|
| Cholinesterase Reactivators | 1 | 2011 | 4 | 0.090 |
Why?
|
| RNA | 3 | 1987 | 266 | 0.090 |
Why?
|
| Behavior, Animal | 1 | 1993 | 373 | 0.080 |
Why?
|
| Mice | 6 | 2025 | 6644 | 0.080 |
Why?
|
| Rats, Inbred Strains | 5 | 1994 | 126 | 0.080 |
Why?
|
| Models, Molecular | 1 | 2013 | 876 | 0.080 |
Why?
|
| Tromethamine | 1 | 1989 | 5 | 0.070 |
Why?
|
| Organ Size | 6 | 1994 | 170 | 0.070 |
Why?
|
| Ion Channel Gating | 3 | 1999 | 82 | 0.070 |
Why?
|
| Excitatory Postsynaptic Potentials | 2 | 2000 | 80 | 0.070 |
Why?
|
| Muscle Contraction | 1 | 1989 | 67 | 0.070 |
Why?
|
| Neurotoxins | 2 | 2000 | 57 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 2 | 2025 | 1869 | 0.070 |
Why?
|
| Social Environment | 3 | 1994 | 218 | 0.060 |
Why?
|
| Kinetics | 2 | 1999 | 695 | 0.060 |
Why?
|
| Brain Chemistry | 3 | 2012 | 141 | 0.060 |
Why?
|
| Cebidae | 1 | 1985 | 4 | 0.060 |
Why?
|
| Saimiri | 1 | 1985 | 6 | 0.060 |
Why?
|
| DEET | 1 | 2025 | 1 | 0.060 |
Why?
|
| Permethrin | 1 | 2025 | 1 | 0.060 |
Why?
|
| Neurotransmitter Agents | 1 | 2006 | 69 | 0.060 |
Why?
|
| Humans | 3 | 2015 | 43102 | 0.060 |
Why?
|
| Object Attachment | 1 | 1985 | 28 | 0.060 |
Why?
|
| Neuronal Plasticity | 1 | 1987 | 126 | 0.060 |
Why?
|
| Acetylcholine | 2 | 1999 | 77 | 0.060 |
Why?
|
| Synaptic Transmission | 2 | 1995 | 149 | 0.050 |
Why?
|
| Xenopus laevis | 3 | 1999 | 73 | 0.050 |
Why?
|
| Nicotine | 2 | 2006 | 302 | 0.050 |
Why?
|
| Cytokines | 2 | 2021 | 678 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 1 | 2024 | 196 | 0.050 |
Why?
|
| Amino Acid Sequence | 3 | 1999 | 1180 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1999 | 267 | 0.040 |
Why?
|
| Ion Channels | 1 | 1999 | 74 | 0.040 |
Why?
|
| Selection, Genetic | 1 | 1980 | 75 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 1999 | 135 | 0.040 |
Why?
|
| Point Mutation | 1 | 1999 | 98 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 1999 | 196 | 0.040 |
Why?
|
| Patch-Clamp Techniques | 1 | 1999 | 228 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1999 | 186 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 1999 | 272 | 0.040 |
Why?
|
| Avoidance Learning | 1 | 1980 | 70 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2021 | 187 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 1999 | 1542 | 0.040 |
Why?
|
| Protein Multimerization | 1 | 1999 | 115 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1999 | 296 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2024 | 2157 | 0.040 |
Why?
|
| Color | 2 | 1990 | 38 | 0.040 |
Why?
|
| omega-Conotoxin GVIA | 1 | 1997 | 5 | 0.030 |
Why?
|
| Binding Sites | 1 | 1999 | 671 | 0.030 |
Why?
|
| Evoked Potentials | 2 | 1995 | 91 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2021 | 1035 | 0.030 |
Why?
|
| Snake Venoms | 1 | 1977 | 2 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2015 | 1621 | 0.030 |
Why?
|
| Cytotoxins | 1 | 1977 | 11 | 0.030 |
Why?
|
| Cell Line | 3 | 2015 | 1410 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2006 | 310 | 0.030 |
Why?
|
| Electrophysiology | 1 | 1995 | 138 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 1995 | 186 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2015 | 60 | 0.030 |
Why?
|
| Injections | 1 | 1974 | 42 | 0.030 |
Why?
|
| Neuroglia | 1 | 2015 | 133 | 0.030 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 1994 | 92 | 0.030 |
Why?
|
| Glucose | 2 | 2015 | 244 | 0.030 |
Why?
|
| DNA | 2 | 1987 | 592 | 0.030 |
Why?
|
| Cnidaria | 1 | 1993 | 8 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 1994 | 187 | 0.020 |
Why?
|
| Body Weight | 3 | 1987 | 429 | 0.020 |
Why?
|
| Terpenes | 1 | 1993 | 30 | 0.020 |
Why?
|
| Histological Techniques | 1 | 2012 | 12 | 0.020 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2012 | 6 | 0.020 |
Why?
|
| Sodium Channels | 1 | 1993 | 65 | 0.020 |
Why?
|
| Catheterization | 1 | 2012 | 22 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2012 | 64 | 0.020 |
Why?
|
| Carboxypeptidases | 1 | 2012 | 8 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2012 | 139 | 0.020 |
Why?
|
| Polyamines | 1 | 1992 | 32 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 458 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2012 | 247 | 0.020 |
Why?
|
| Cyclohexylamines | 1 | 1990 | 14 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 1990 | 60 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 883 | 0.020 |
Why?
|
| Medulla Oblongata | 1 | 1990 | 42 | 0.020 |
Why?
|
| Cerebellum | 1 | 1990 | 79 | 0.020 |
Why?
|
| Chemistry | 1 | 1989 | 15 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 587 | 0.020 |
Why?
|
| Rana pipiens | 1 | 1989 | 63 | 0.020 |
Why?
|
| Chemical Phenomena | 1 | 1989 | 56 | 0.020 |
Why?
|
| Aging | 1 | 1994 | 783 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 1990 | 172 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 704 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 2676 | 0.020 |
Why?
|
| Social Isolation | 2 | 1994 | 34 | 0.020 |
Why?
|
| Synaptophysin | 1 | 2006 | 6 | 0.020 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2006 | 52 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2006 | 83 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2006 | 157 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 652 | 0.010 |
Why?
|
| Social Behavior | 1 | 1985 | 161 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2006 | 986 | 0.010 |
Why?
|
| Organ Specificity | 2 | 1993 | 141 | 0.010 |
Why?
|
| Oocytes | 2 | 1993 | 149 | 0.010 |
Why?
|
| Recombinant Proteins | 2 | 1993 | 518 | 0.010 |
Why?
|
| Arousal | 1 | 1979 | 95 | 0.010 |
Why?
|
| Models, Structural | 1 | 1977 | 12 | 0.010 |
Why?
|
| Motor Activity | 1 | 1979 | 437 | 0.010 |
Why?
|
| Molecular Conformation | 1 | 1977 | 155 | 0.010 |
Why?
|
| Sensory Deprivation | 1 | 1974 | 7 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 1974 | 36 | 0.010 |
Why?
|
| Occipital Lobe | 1 | 1994 | 5 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 1974 | 54 | 0.010 |
Why?
|
| Mental Recall | 1 | 1994 | 84 | 0.010 |
Why?
|
| Receptors, AMPA | 1 | 1994 | 58 | 0.010 |
Why?
|
| Brain Mapping | 1 | 1994 | 137 | 0.010 |
Why?
|
| Nucleus Accumbens | 1 | 1994 | 100 | 0.010 |
Why?
|
| Tetracaine | 1 | 1993 | 4 | 0.010 |
Why?
|
| Cnidarian Venoms | 1 | 1993 | 24 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 1973 | 110 | 0.010 |
Why?
|
| Magnesium | 1 | 1993 | 94 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 1993 | 222 | 0.010 |
Why?
|
| Rubidium | 1 | 1992 | 6 | 0.010 |
Why?
|
| Bungarotoxins | 1 | 1992 | 21 | 0.010 |
Why?
|
| Research Design | 1 | 1974 | 385 | 0.010 |
Why?
|
| Carbachol | 1 | 1992 | 18 | 0.010 |
Why?
|
| Water | 1 | 1974 | 316 | 0.010 |
Why?
|
| Blood Glucose | 1 | 1994 | 389 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1992 | 109 | 0.010 |
Why?
|
| Ligands | 1 | 1993 | 388 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1993 | 570 | 0.010 |
Why?
|
| Pituitary Gland | 1 | 1970 | 60 | 0.010 |
Why?
|
| Time Factors | 1 | 1974 | 1857 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1992 | 403 | 0.000 |
Why?
|
| Protein Binding | 1 | 1993 | 1082 | 0.000 |
Why?
|
| Environmental Exposure | 1 | 1970 | 256 | 0.000 |
Why?
|
| Carbon Isotopes | 1 | 1973 | 34 | 0.000 |
Why?
|
| Culture Media | 1 | 1973 | 96 | 0.000 |
Why?
|